Research Field

The drug development system is broken; the COVID-19 pandemic is an opportunity to take a bold step towards accessible and affordable therapies

How primary neuronal cell cultures are unraveling the role of amyloid β oligomers in Alzheimer’s disease.

Sitting Down With… Mike Clayman, CEO of Flexion Therapeutics, Inc., Burlington, Massachusetts, USA.

Sitting Down with Michael Tanner, Research Fellow in the School of Engineering and Physical Sciences at Heriot Watt University, Edinburgh, UK.

RNA Inhibitors - an exciting avenue for drug development? We collate the findings from the Innovation that Matters series, hosted by WuXi Xpress...

Researchers fine-tune 3D printing technology to create better biomimetic corneas – and predict a “breakthrough” in global transplantation practice.

To truly understand the intricacies of pathogenic bacteria, we need to combine “pure” and translational research.

Meet the researchers uncovering the secrets of tissue regeneration.

How advanced studies into the microorganisms we harbor could impact cancer prevention, treatment, and prognosis.

How functionally polarized full-thickness tissue regeneration, artificial intelligence and advanced 3D printing hold the keys to advanced wound repair